Evaluation of the Chemo-mechanical Caries Removal Agent (BRIX3000®) in Primary Molars
Clinical and Microbiological Evaluation of the Chemo-mechanical Caries Removal Agent (BRIX3000®) in Primary Molars: A Randomized Controlled Clinical Trial.
1 other identifier
interventional
60
1 country
1
Brief Summary
Dental caries is one of the most prevalent chronic diseases in people worldwide. Traditional clinical treatment of dental decay has developed on the basis of the removal of carious tissues with high-speed handpieces and slow-rotating instruments, inducing pain, disturbing sounds, and vibrations. In addition, this method comprises the tooth structure by removing both "caries-affected dentin" and "caries-infected dentin". The use of the chemo-mechanical caries removal (CMCR) method is one of the main implementations of the minimal intervention dentistry idea accepted in the last ten years. It includes the selective removal of "caries-infected dentin" while preserving the healthy "caries-affected dentin" that has the ability to remineralize. The CMCR method differs from the traditional surgical method in that it selectively removes carious dentin. Therefore, it is less destructive and less painful, thereby promoting a positive attitude towards visiting dentists. A novel agent for the CMCR method named "BRIX3000®" by the laboratory Brix Medical Science has been released onto the dental market in 2016. It is a papain-based gel derived from latex and fruits of green papaya (Carica Papaya) that works as a chemical debridement with a unique technology called Encapsulating Buffer Emulsion (EPE). Investigations are required to evaluate and compare the outcomes of two CMCR agents, "BRIX3000®" and "Carie-CareTM," versus the traditional surgical methods. Therefore, the present study aims to perform a clinical and microbiological evaluation of caries removal using "BRIX3000®" and "Carie-CareTM" versus the traditional surgical methods in primary molars among children in Jeddah city, Saudi Arabia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedFirst Posted
Study publicly available on registry
June 22, 2022
CompletedJune 22, 2022
June 1, 2022
1.2 years
June 25, 2019
June 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The efficacy of caries removal
A change in the total viable count (TVC) of dentin samples taken during the dental treatment session is being assessed and presented as colony forming unit (CFU) per mL of sample.
through study completion, an average of 1 year
Secondary Outcomes (2)
The efficiency of caries removal
through study completion, an average of 1 year
The pain perception during caries removal
through study completion, an average of 1 year
Study Arms (4)
Group (1A)
EXPERIMENTAL30 children with 60 primary molars underwent caries removal by the CMCR method "BRIX3000®" (the experimental group) on one molar (n = 30).
Group (1C)
ACTIVE COMPARATOR30 children with 60 primary molars underwent caries removal by the traditional surgical method (the control group) on the contralateral molar (n = 30).
Group (2B)
EXPERIMENTAL30 children with 60 primary molars underwent caries removal by the CMCR method "Carie-CareTM" " (the experimental group) on one molar (n = 30).
Group (2C)
ACTIVE COMPARATOR30 children with 60 primary molars underwent caries removal by the traditional surgical method (the control group) on the contralateral molar (n = 30).
Interventions
In group(1A), the chemomechanical caries removal agent "BRIX3000®" was used for caries removal in primary molars.
In group(1C), the traditional surgical method (high-speed and low-speed air-rotors) was used for caries removal in primary molars.
In group(2B), the chemomechanical caries removal agent "Carie-CareTM" was used for caries removal in primary molars.
In group(2C), the traditional surgical method (high-speed and low-speed air-rotors) was used for caries removal in primary molars.
Eligibility Criteria
You may qualify if:
- Healthy and cooperative patients of age group 4-9 years.
- Primary first/second molars with open occlusal carious lesion having moderated depth and clinically visible brownish color softened dentin.
- No clinical signs or symptoms of pulp degeneration, such as tenderness to percussion and history of sinus tracts or swelling. Intraoral periapical radiographs with lesions having radiolucency extending into, but only confined to dentin.
You may not qualify if:
- Patients with any major and minor systemic illness.
- Uncooperative patients that necessitate pharmacological dental treatment.
- Primary molars with mobile teeth, arrested caries, restored teeth, non-vital teeth, no carious lesion, presence of developmental defects and non-restorable teeth.
- Patients on any antibiotic regimen either on the day of treatment or for at least 2 weeks prior to the study.
- Patients allergic to Latex.
- Radiographic evidence of external or internal root resorption, furcal or periapical radiolucency.
- Primary molars with more than half of the root length resorbed.
- Children who did not attend and complete the second session of treatment.
- Not approving to sign the consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Abdulaziz University, Dental University Hospital
Jeddah, Mecca Region, 80209, Saudi Arabia
Related Publications (1)
Maashi M, Elkhodary H, Bamashmous N, Felemban O, Alamoudi N. Clinical performance of two chemomechanical caries removal agents in primary molars: a randomized controlled trial. Eur Arch Paediatr Dent. 2025 Aug;26(4):731-739. doi: 10.1007/s40368-025-01030-9. Epub 2025 Apr 9.
PMID: 40205159DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Heba M Elkhodary, D.Sc.
King Abdulaziz University
- PRINCIPAL INVESTIGATOR
Najla'a M AL-Amoudi, D.Sc.
King Abdulaziz University
- STUDY CHAIR
Manal S Maashi, M.Sc.
King Abdulaziz University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
June 25, 2019
First Posted
June 22, 2022
Study Start
October 1, 2019
Primary Completion
December 30, 2020
Study Completion
January 1, 2021
Last Updated
June 22, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The data will become available within 18 months starting from 1st July 2019 for unlimited time.
- Access Criteria
- Public
All IPD that underlie results in a publication